Radio-LC-MS for the characterization of 99mTc-labeled bioconjugates

被引:37
作者
Liu, S [1 ]
Ziegler, MC [1 ]
Edwards, DS [1 ]
机构
[1] DuPont Pharmaceut Co, Med Imaging Div, N Billerica, MA 01862 USA
关键词
D O I
10.1021/bc990111r
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This report describes the first example of using radio-LC-MS for determining the composition of Tc-99m radiopharmaceuticals at the tracer level. The in-line radiometric detector is a useful addition to a standard LC-MS and provides direct correlation between the MS data and the radioactive species in a radiopharmaceutical kit. Complexes [Tc-99m(HYNICtide)(tricine)(L)] (RP444, L = TPPTS; RP445, L = TPPDS; and RP446, L = TPPMS) were prepared using a decayed generator eluant. All the ternary ligand Tc-99m complexes show the expected monoprotonated molecular ions, (M + 1)(+), and diprotonated molecular ions, (M + 2)(2+). The LC-MS spectral data support the proposed structure and are consistent with those obtained for their corresponding Tc-99 analogues. Ternary ligand complexes [Tc-99m(HYNICtide)(tricine)(L)] (L = ISONIC-HE and ISONIC-Sorb) are neutral, and the molecular weights are also lower than that of RP444. Using a fresh generator eluant (24 h prior elution), only 1-2 mCi of Tc-99m [(7 x 10(-12))-(1.5 x 10(-11)) mol of technetium complex] are required to obtain a reasonably clean mass spectrum. Radio-LC-MS is a quick and accurate analytical tool for characterization of Tc-99m radiopharmaceuticals at the tracer level.
引用
收藏
页码:113 / 117
页数:5
相关论文
共 15 条
[1]   Radiometal labeled agents (non-technetium) for diagnostic imaging [J].
Anderson, CJ ;
Welch, MJ .
CHEMICAL REVIEWS, 1999, 99 (09) :2219-2234
[2]   LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY WITH IONSPRAY AND ELECTROSPRAY INTERFACES IN PHARMACEUTICAL AND BIOMEDICAL-RESEARCH [J].
BRUINS, AP .
JOURNAL OF CHROMATOGRAPHY, 1991, 554 (1-2) :39-46
[3]   New and versatile ternary ligand system for technetium radiopharmaceuticals: Water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with Tc-99m [J].
Edwards, DS ;
Liu, S ;
Barrett, JA ;
Harris, AR ;
Looby, RJ ;
Ziegler, MC ;
Heminway, SJ ;
Carroll, TR .
BIOCONJUGATE CHEMISTRY, 1997, 8 (02) :146-154
[4]   BIOMEDICAL AND BIOCHEMICAL APPLICATIONS OF LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
GELPI, E .
JOURNAL OF CHROMATOGRAPHY A, 1995, 703 (1-2) :59-80
[5]  
Hyllbrant B., 1997, Journal of Labelled Compounds and Radiopharmaceuticals, V40, P197
[6]  
Hyllbrant Benita, 1995, Journal of Labelled Compounds and Radiopharmaceuticals, V37, P704
[7]   Potential technetium small molecule radiopharmaceuticals [J].
Jurisson, SS ;
Lydon, JD .
CHEMICAL REVIEWS, 1999, 99 (09) :2205-2218
[8]  
Lee MS, 1997, LC GC-MAG SEP SCI, V15, P542
[9]   A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands [J].
Liu, S ;
Edwards, DS ;
Harris, AR .
BIOCONJUGATE CHEMISTRY, 1998, 9 (05) :583-595
[10]   Technetium complexes of a hydrazinonicotinamide-conjugated cyclic peptide and 2-hydrazinopyridine: Synthesis and characterization [J].
Liu, S ;
Edwards, DS ;
Harris, AR ;
Heminway, SJ ;
Barrett, JA .
INORGANIC CHEMISTRY, 1999, 38 (06) :1326-1335